Works matching IS 00316970 AND DT 2023 AND VI 79 AND IP 7
Results: 13
Failure to predict amikacin elimination in critically ill patients with cancer based on the estimated glomerular filtration rate: applying PBPK approach in a therapeutic drug monitoring study.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 1003, doi. 10.1007/s00228-023-03516-1
- By:
- Publication type:
- Article
Correction to: Potentially inappropriate medications and cognitive performance: cross‑sectional results from the ELSA–Brasil study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Seronegative acute encephalitis following COVID-19 vaccines: a case series of an overlooked diagnosis with literature review.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 975, doi. 10.1007/s00228-023-03510-7
- By:
- Publication type:
- Article
Safety of SGLT2 inhibitors in patients with different glomerular diseases treated with immunosuppressive therapies.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 961, doi. 10.1007/s00228-023-03508-1
- By:
- Publication type:
- Article
Alogliptin: a DPP-4 inhibitor modulating adipose tissue insulin resistance and atherogenic lipid.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 947, doi. 10.1007/s00228-023-03506-3
- By:
- Publication type:
- Article
Prevalence and bleeding risk associated with the concomitant use of direct oral anticoagulants and antiarrhythmic drugs in patients with atrial fibrillation, based on the French healthcare insurance database.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 937, doi. 10.1007/s00228-023-03501-8
- By:
- Publication type:
- Article
Potentially inappropriate medications and cognitive performance: cross-sectional results from the ELSA–Brasil study.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 927, doi. 10.1007/s00228-023-03504-5
- By:
- Publication type:
- Article
Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 897, doi. 10.1007/s00228-023-03503-6
- By:
- Publication type:
- Article
Lenvatinib in the treatment of unresectable hepatocellular carcinoma: a systematic review of economic evaluations.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 885, doi. 10.1007/s00228-023-03502-7
- By:
- Publication type:
- Article
Imprecision in vaccine adverse event reporting and a methodological analysis of reporting systems to improve pharmacovigilance and public health.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 989, doi. 10.1007/s00228-023-03505-4
- By:
- Publication type:
- Article
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 967, doi. 10.1007/s00228-023-03499-z
- By:
- Publication type:
- Article
Dapagliflozin reduces risk of heart failure rehospitalization in diabetic acute myocardial infarction patients: a propensity score-matched analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 915, doi. 10.1007/s00228-023-03495-3
- By:
- Publication type:
- Article
Linezolid-associated serotonin toxicity: a systematic review.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 875, doi. 10.1007/s00228-023-03500-9
- By:
- Publication type:
- Article